Search for Clinical Trial Results

Sponsored By

Epilepsy, Generalized - 25 Studies Found

Status Study
Completed Study Name: Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy
Condition: Generalized Epilepsy
Date: 2005-09-06
Interventions:
  • Drug: Levetiracetam 166 mg

Completed Study Name: Blinking and Yawning in Epilepsy: The Role of Dopamine
Condition: Idiopathic Generalized Epilepsy
Date: 2011-06-14
Interventions: Other: Apomorphine (Experimental product) Dosage Form: Inj
Completed Study Name: Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy
Condition: Generalized Epilepsy
Date: 2005-09-06
Interventions: Drug: LEVETIRACETAM
Completed Study Name: Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures
Condition: Generalized Convulsive Epilepsy
Date: 2005-09-08
Interventions: Drug: Levetiracetam
Recruiting Study Name: A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications
Condition: Epilepsy
Date: 2015-03-31
Interventions:
  • Drug: Lacosamide Tablet

Terminated Study Name: Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy
Condition: Epilepsy
Date: 2008-06-03
Interventions:
  • Drug: Zonisamide

Completed Study Name: Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults
Condition: Generalized Convulsive Epilepsy
Date: 2005-09-06
Interventions: Drug: Levetiracetam
Completed Study Name: Clobazam in Patients With Lennox-Gastaut Syndrome
Condition:
  • Epilepsy
  • Epilepsy, Generalized
  • Drug: Clobazam Low Dose 0.25 m
Completed Study Name: Clobazam in Subjects With Lennox-Gastaut Syndrome
Condition:
  • Epilepsy
  • Epilepsy, Generalized
  • Drug: Clobazam Low Dose 5 to 1
Completed Study Name: Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
Condition: Epilepsy
Date: 2010-05-05
Interventions: Drug: Lacosamide Lacosamide is supplied as 50 mg, 100 mg, 150 mg, and 200 mg tablets. Subjects will begi
Next >>>